miR-132 regulates the differentiation of dopamine neurons by directly targeting Nurr1 expression - PubMed (original) (raw)
. 2012 Apr 1;125(Pt 7):1673-82.
doi: 10.1242/jcs.086421. Epub 2012 Feb 10.
Affiliations
- PMID: 22328530
- DOI: 10.1242/jcs.086421
miR-132 regulates the differentiation of dopamine neurons by directly targeting Nurr1 expression
Dehua Yang et al. J Cell Sci. 2012.
Abstract
Although it is well established that embryonic stem (ES) cells have the potential to differentiate into dopamine neurons, the molecular basis of this process, particularly the role of microRNAs (miRNAs), remains largely unknown. Here we report that miR-132 plays a key role in the differentiation of dopamine neurons by directly regulating the expression of Nurr1 (also known as nuclear receptor subfamily 4 group A member 2; Nr4a2). We constructed a mouse ES cell line CGR8, which stably expresses GFP under the tyrosine hydroxylase (TH) promoter, so the TH-positive neurons could be easily sorted using fluorescence-activated cell sorting (FACS). Then, we performed a miRNA array analysis on the purified TH-positive neurons and found that 45 of 585 miRNAs had more than a fivefold change in expression level during dopamine neuron differentiation. Among the 45 miRNAs, we were particularly interested in miR-132 because this miRNA has been reported to be highly expressed in neurons and to have a potential role in neurodegenerative diseases. We found that the direct downregulation of endogenous miR-132 induced by miR-132 antisense oligonucleotide (miR-132-ASO) promoted the differentiation of TH-positive neurons, whereas ectopic expression of miR-132 in ES cells reduced the number of differentiated TH-positive neurons but did not change the total number of differentiated neurons. Furthermore, we identified that miR-132-ASO could substantially reverse the miR-132-mediated suppression of TH-positive neuron differentiation. Moreover, through a bioinformatics assay we identified the Nurr1 gene as a potential molecular target of miR-132. Using a luciferase-reporter assay and western blot analysis, we demonstrated that miR-132 could directly regulate the expression of Nurr1. Collectively, our data provide the first evidence that miR-132 is an important molecule regulating ES cell differentiation into dopamine neurons by directly targeting Nurr1 gene expression.
Similar articles
- Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
Chang YL, Chen SJ, Kao CL, Hung SC, Ding DC, Yu CC, Chen YJ, Ku HH, Lin CP, Lee KH, Chen YC, Wang JJ, Hsu CC, Chen LK, Li HY, Chiou SH. Chang YL, et al. Cell Transplant. 2012;21(1):313-32. doi: 10.3727/096368911X580572. Epub 2011 Jun 7. Cell Transplant. 2012. PMID: 21669041 - Prolonged membrane depolarization enhances midbrain dopamine neuron differentiation via epigenetic histone modifications.
He XB, Yi SH, Rhee YH, Kim H, Han YM, Lee SH, Lee H, Park CH, Lee YS, Richardson E, Kim BW, Lee SH. He XB, et al. Stem Cells. 2011 Nov;29(11):1861-73. doi: 10.1002/stem.739. Stem Cells. 2011. PMID: 21922608 - Retinoid X receptor α acts as a negative regulator in Nurr1-induced dopaminergic differentiation in rat neural precursor cells.
Yoon EH, Lee KJ, Kim YS, Chang MS, Lee SH, Park CH. Yoon EH, et al. Neuroreport. 2010 Dec 29;21(18):1162-6. Neuroreport. 2010. PMID: 22066143 - The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease.
Jankovic J, Chen S, Le WD. Jankovic J, et al. Prog Neurobiol. 2005 Sep-Oct;77(1-2):128-38. doi: 10.1016/j.pneurobio.2005.09.001. Epub 2005 Oct 21. Prog Neurobiol. 2005. PMID: 16243425 Review. - NURR1 in Parkinson disease--from pathogenesis to therapeutic potential.
Decressac M, Volakakis N, Björklund A, Perlmann T. Decressac M, et al. Nat Rev Neurol. 2013 Nov;9(11):629-36. doi: 10.1038/nrneurol.2013.209. Epub 2013 Oct 15. Nat Rev Neurol. 2013. PMID: 24126627 Review.
Cited by
- microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches.
Leggio L, Vivarelli S, L'Episcopo F, Tirolo C, Caniglia S, Testa N, Marchetti B, Iraci N. Leggio L, et al. Int J Mol Sci. 2017 Dec 13;18(12):2698. doi: 10.3390/ijms18122698. Int J Mol Sci. 2017. PMID: 29236052 Free PMC article. Review. - The Stress-Responding miR-132-3p Shows Evolutionarily Conserved Pathway Interactions.
Haviv R, Oz E, Soreq H. Haviv R, et al. Cell Mol Neurobiol. 2018 Jan;38(1):141-153. doi: 10.1007/s10571-017-0515-z. Epub 2017 Jun 30. Cell Mol Neurobiol. 2018. PMID: 28667373 Free PMC article. - Antisense miR-132 blockade via the AChE-R splice variant mitigates cortical inflammation.
Mishra N, Friedson L, Hanin G, Bekenstein U, Volovich M, Bennett ER, Greenberg DS, Soreq H. Mishra N, et al. Sci Rep. 2017 Feb 17;7:42755. doi: 10.1038/srep42755. Sci Rep. 2017. PMID: 28209997 Free PMC article. - Undifferentiated embryonic stem cells express ionotropic glutamate receptor mRNAs.
Pachernegg S, Joshi I, Muth-Köhne E, Pahl S, Münster Y, Terhag J, Karus M, Werner M, Ma-Högemeier ZL, Körber C, Grunwald T, Faissner A, Wiese S, Hollmann M. Pachernegg S, et al. Front Cell Neurosci. 2013 Dec 3;7:241. doi: 10.3389/fncel.2013.00241. eCollection 2013. Front Cell Neurosci. 2013. PMID: 24348335 Free PMC article. - Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology.
Burgos K, Malenica I, Metpally R, Courtright A, Rakela B, Beach T, Shill H, Adler C, Sabbagh M, Villa S, Tembe W, Craig D, Van Keuren-Jensen K. Burgos K, et al. PLoS One. 2014 May 5;9(5):e94839. doi: 10.1371/journal.pone.0094839. eCollection 2014. PLoS One. 2014. PMID: 24797360 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials